Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wupeng Wan
- Development stage
- Unknown
- Lead developer
- Xizang Ganlu Tibetan Medicine and Herbal Resources Development
- Administration
- Oral
01
Overview
Wupeng Wan is a traditional Tibetan medicine (TTM) manufactured by Xizang Ganlu Tibetan Medicine. It is an approved pharmaceutical product in China, registered under the National Drug License Number Z54020049. The formulation is based on traditional Tibetan medical principles and is primarily indicated for its anti-inflammatory and analgesic properties. It is used clinically to treat conditions such as rheumatoid arthritis, rheumatism, and various inflammatory skin disorders, including eczema and pruritus (itching). The name 'Wupeng' (or Khung-nga in Tibetan) refers to the 'Five Garuda' formula, which typically incorporates five core ingredients: Aconitum szechenyianum (铁棒锤), Terminalia chebula (诃子), Aconitum pendulum (榜嘎), Trogopterus dung (五灵脂), and Musk (麝香). The medicine is intended to balance the bodily humors, specifically clearing heat and detoxifying the system to alleviate pain and inflammation.
- Brand names
- Ganlu
- Other names
- 五鹏丸Wupeng PillsKhung-ngaFive-Ingredient Garuda Pill
Beyond the preview
Go deeper on Wupeng Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wupeng Wan.